Organism name | Spartium junceum |
---|---|
Genus | Spartium |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Spartium junceum |
---|---|
Linked NCBI taxonomy ID | 49843 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004114
![]() |
Chrysin 7-gentiobioside
|
No. 1 | No. 15 |
![]() |
||||
C00004110
![]() |
Aequinetin
|
C013884
|
No. 2 | No. 15 |
![]() |
|||
C00002528
![]() |
Genistin
/ Genistoside / Genistein 7-O-glucoside / Genistein 7-O-beta-glucopyranoside |
CHEMBL486625
CHEMBL1364260 |
C040641
|
15 / 32 / 53 | 6 / 2 | No. 2 | No. 15 |
![]() |
C00004276
![]() |
Juncein
/ Luteolin 4'-glucoside / Luteolin 4'-O-beta-D-glucopyranoside / 5,7,3',4'-Tetrahydroxyflavone 4'-beta-D-glucopyranoside |
CHEMBL459822
|
No. 2 | No. 15 |
![]() |
|||
C00002525
![]() |
Formononetin
/ 7-Hydroxy-4'-methoxyisoflavone |
CHEMBL242341
|
C007768
|
24 / 36 / 58 | 13 / 0 | No. 3 | No. 15 |
![]() |
C00040338
![]() |
Spartitrioside
/ (-)-Spartitrioside |
No. 9 | No. 51 |
![]() |
||||
C00008487
![]() |
Isocarthamidin 7-O-rhamnoside
|
No. 12 | No. 14 |
![]() |
||||
C00001110
![]() |
Vitexin
/ Apigenin 8-C-glucoside / 8-D-Glucosyl-4',5,7-trihydroxyflavone / 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL487417
CHEMBL1332209 CHEMBL1357921 |
16 / 4 / 8 | No. 22 | No. 15 |
![]() |
||
C00000919
![]() |
beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
D019207
|
7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |
![]() |
C00002574
![]() |
(-)-Sparticarpin
|
No. 66 | No. 15 |
![]() |
||||
C00009453
![]() |
2'-Hydroxygenistein
|
CHEMBL6665
|
8 / 6 / 5 | No. 71 | No. 15 |
![]() |
||
C00003794
![]() |
Chrysin
/ 5,7-Dihydroxyflavone / 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one |
CHEMBL117
|
C043561
|
100 / 89 / 87 | 69 / 6 | No. 76 | No. 15 |
![]() |
C00002225
![]() |
Lupanine
/ (+)-Lupanine |
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
C008298
|
No. 85 | No. 3 |
![]() |
||
C00007692
![]() |
17-Oxosparteine
|
CHEMBL509343
|
C035707
|
No. 85 | No. 3 |
![]() |
||
C00001260
![]() |
Nonacosane
|
CHEMBL428955
|
C047577
|
No. 115 |
![]() |
|||
C00002234
![]() |
Rhombifoline
/ (-)-Rhombifoline |
CHEMBL1397610
|
C119591
|
No. 376 | No. 3 |
![]() |
||
C00007735
![]() |
N-Formylcytisine
/ (-)-N-Formylcytisine |
CHEMBL1396784
CHEMBL1433686 |
4 / 6 / 11 | No. 376 | No. 3 |
![]() |
||
C00002216
![]() |
Caulophylline
/ N-Methylcytisine / (-)-N-Methylcytisine |
CHEMBL66191
CHEMBL1085045 |
C034245
|
No. 376 | No. 3 |
![]() |
||
C00007736
![]() |
N-Acetylcytisine
|
CHEMBL1513538
CHEMBL1553838 |
2 / 3 / 7 | No. 376 | No. 3 |
![]() |
||
C00002238
![]() |
Thermopsine
/ (-)-Thermopsine |
CHEMBL203399
CHEMBL509692 CHEMBL1324708 CHEMBL1454284 |
C059560
|
7 / 8 / 11 | No. 384 | No. 3 |
![]() |
|
C00002239
![]() |
Tinctorine
/ (-)-Tinctorine |
No. 384 | No. 3 |
![]() |
||||
C00007722
![]() |
Epibaptifoline
/ (-)-Epibaptifoline |
No. 384 | No. 3 |
![]() |
||||
C00007682
![]() |
beta-Isosparteine
|
CHEMBL412873
CHEMBL44625 CHEMBL172633 CHEMBL1328708 CHEMBL1492771 CHEMBL1740920 CHEMBL1908847 CHEMBL2010478 |
93 / 50 / 48 | No. 424 | No. 3 |
![]() |
||
C00002219
![]() |
5,6-Dehydrolupanine
|
No. 555 | No. 3 |
![]() |
||||
C00000615
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 904 | No. 6 |
![]() |
||
C00007730
![]() |
Tetrahydrorhombifoline
|
CHEMBL460224
|
No. 1023 | No. 3 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000615 C00002238 C00002525 C00003794 C00007682 C00007735 C00007736 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00000615 C00002238 C00002525 C00003794 C00007682 C00007735 C00007736 | 2 / 5 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000615 C00001110 C00002238 C00002525 C00003794 C00007682 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000615 C00001110 C00002238 C00002525 C00003794 C00007682 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000615 C00001110 C00002525 C00003794 C00007682 C00007735 | 0 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000615 C00000919 C00002238 C00002525 C00003794 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000615 C00002238 C00002525 C00003794 C00007735 | 3 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000615 C00001110 C00002525 C00003794 C00007682 | 0 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000615 C00002525 C00003794 C00009453 | 4 / 3 |
P02545 | Prelamin-A/C | Unclassified protein | C00000615 C00000919 C00002528 C00007682 | 11 / 10 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000615 C00002525 C00002528 C00003794 | 2 / 2 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000615 C00002238 C00002525 C00003794 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000919 C00001110 C00002528 C00003794 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000615 C00001110 C00003794 C00007682 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000615 C00001110 C00009453 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000615 C00001110 C00002525 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000615 C00003794 C00007682 | 0 / 3 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000615 C00002528 C00007682 | 1 / 8 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002525 C00002528 C00003794 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000615 C00003794 C00007682 | 1 / 2 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002525 C00002528 C00003794 | 7 / 37 |
P03372 | Estrogen receptor | NR3A1 | C00000615 C00003794 C00007682 | 1 / 1 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002525 C00002528 C00003794 | 4 / 2 |
P15121 | Aldose reductase | Enzyme | C00000615 C00001110 C00003794 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000615 C00001110 C00009453 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000615 C00003794 C00007682 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002525 C00002528 C00003794 | 4 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001110 C00009453 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00003794 C00007682 | 0 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000615 C00002528 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002525 C00003794 | 5 / 3 |
P14679 | Tyrosinase | Oxidoreductase | C00000615 C00003794 | 4 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002525 C00003794 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000615 C00007682 | 2 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00003794 C00007682 | 0 / 1 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000615 C00003794 | 0 / 1 |
P03956 | Interstitial collagenase | M10A | C00000615 C00007682 | 0 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000615 C00009453 | 1 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000615 C00003794 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002528 C00009453 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000615 C00003794 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00000615 C00009453 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 C00007682 | 1 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00002525 C00003794 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 C00007682 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 C00007682 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003794 C00007682 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000615 C00003794 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003794 C00007682 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000615 C00003794 | 1 / 2 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00002525 C00003794 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000615 C00007682 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 C00007682 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000615 C00007682 | 2 / 2 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001110 C00009453 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002525 C00003794 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001110 | 0 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00003794 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00007682 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00007682 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00007682 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00003794 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00003794 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00003794 | 0 / 0 |
O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00003794 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00000615 | 1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002528 | 1 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00003794 | 1 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00003794 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00007682 | 2 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00007682 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00007682 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00007682 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00007682 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00007682 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000615 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00007682 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00003794 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00007682 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00007682 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00007682 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000615 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00007682 | 0 / 0 |
P16581 | E-selectin | Adhesion | C00003794 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00007682 | 1 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00003794 | 1 / 1 |
P35367 | Histamine H1 receptor | Histamine receptor | C00007682 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00007682 | 0 / 0 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000615 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000615 | 0 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00003794 | 1 / 1 |
P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00003794 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003794 | 2 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00003794 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002528 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000615 | 3 / 1 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00003794 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00007682 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00007682 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00007682 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00007682 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00007682 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00007682 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00007682 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00007682 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000615 | 3 / 2 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00007682 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00007682 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00007682 | 1 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003794 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00007682 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00007682 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00007682 | 1 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003794 | 0 / 0 |
P62158 | Calmodulin | Unclassified protein | C00003794 | 1 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00007682 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003794 | 7 / 3 |
P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00003794 | 1 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001110 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002525 | 0 / 0 |
P51843 | Nuclear receptor subfamily 0 group B member 1 | Nuclear hormone receptor subfamily 0 group B member 1 | C00003794 | 2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001110 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00007682 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00007682 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00003794 | 2 / 2 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00007682 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00007682 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00007682 | 2 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00007682 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00007682 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00007682 | 1 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00003794 | 4 / 4 |
P21452 | Substance-K receptor | Neurokinin receptor | C00007682 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00007682 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00007682 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00007682 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00000615 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003794 | 0 / 0 |
P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00000615 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00007682 | 1 / 0 |
P29466 | Caspase-1 | C14 | C00007682 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00007682 | 2 / 1 |
Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00000615 | 4 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000615 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00000615 | 1 / 3 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000615 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00003794 | 2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00003794 | 1 / 1 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000615 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000615 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002528 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000615 | 5 / 2 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00007682 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00003794 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00007682 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00007682 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000615 | 3 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00007682 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00007682 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00007682 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00007682 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00007682 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00007682 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00007682 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00007682 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000615 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003794 | 0 / 0 |
P14151 | L-selectin | Adhesion | C00003794 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00003794 | 1 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00007682 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00003794 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00007682 | 2 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00007682 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00007682 | 0 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000615 | 1 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000615 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000615 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00003794 | 5 / 1 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000615 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003794 | 1 / 1 |
P10275 | Androgen receptor | NR3C4 | C00003794 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00007682 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00007682 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00007682 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00003794 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00007682 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00007682 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000615 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000615 | 1 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00003794 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00003794 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00007682 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000615 | 1 / 1 |
Q12794 | Hyaluronidase-1 | Enzyme | C00000615 | 1 / 2 |
P31639 | Sodium/glucose cotransporter 2 | Glucose | C00002525 | 1 / 1 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00000615 | 0 / 0 |
P13866 | Sodium/glucose cotransporter 1 | Glucose | C00002525 | 1 / 1 |
P56937 | 3-keto-steroid reductase | Enzyme | C00003794 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000615 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000615 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002528 | 1 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000615 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00003794 | 3 / 0 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00000615 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001110 | 1 / 4 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00003794 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00003794 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00003794 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00003794 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00003794 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00003794 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00003794 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00003794 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00003794 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00003794 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00003794 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00003794 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00003794 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00003794 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00003794 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00003794 | 1 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00003794 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00003794 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00003794 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00003794 | 0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00000615 | 0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | C00000615 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00003794 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003794 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00003794 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00003794 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002528 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000919
C00002525
C00003794
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000919
C00002525
C00003794
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002525
C00003794
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002525
C00003794
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000919
C00003794
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002525
C00003794
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002525
C00003794
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000919
C00003794
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002525
C00003794
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002525
C00003794
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002525
C00003794
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002525
C00003794
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002525
C00003794
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000919
C00003794
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000919
C00003794
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000919
C00003794
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000919
C00003794
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000919
C00003794
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000919
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00003794
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00003794
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00003794
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00003794
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00003794
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003794
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00003794
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003794
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00003794
|
4502 | MT2A, MT2 | metallothionein 2A |
C00002528
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003794
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00003794
|
891 | CCNB1, CCNB | cyclin B1 |
C00003794
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003794
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00003794
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003794
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003794
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00003794
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00002528
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00002528
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003794
|
9415 | FADS2, D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13 | fatty acid desaturase 2 (EC:1.14.19.-) |
C00003794
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00003794
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00003794
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00003794
|
3122 | HLA-DRA, HLA-DRA1, MLRW | major histocompatibility complex, class II, DR alpha |
C00003794
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003794
|
3600 | IL15, IL-15 | interleukin 15 |
C00003794
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00002528
|
3554 | IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80 | interleukin 1 receptor, type I |
C00003794
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00003794
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00003794
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00002528
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003794
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003794
|
5335 | PLCG1, NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1 | phospholipase C, gamma 1 (EC:3.1.4.11) |
C00003794
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00003794
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00003794
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003794
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003794
|
6309 | SC5D, ERG3, S5DES, SC5DL | sterol-C5-desaturase (EC:1.14.21.6) |
C00003794
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00003794
|
2810 | SFN, YWHAS | stratifin |
C00003794
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00003794
|
6783 | SULT1E1, EST, EST-1, ST1E1, STE | sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) |
C00003794
|
29110 | TBK1, NAK, T2K | TANK-binding kinase 1 (EC:2.7.11.1) |
C00003794
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00003794
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002525
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002525
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003794
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00003794
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00003794
|
7161 | TP73, P73 | tumor protein p73 |
C00003794
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00003794
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00003794
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00003794
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00003794
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00003794
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00000919
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00000919
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000919
|
8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) |
C00000919
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000919
|
288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) |
C00000919
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00000919
|
51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00000919
|
140462 | ASB9 | ankyrin repeat and SOCS box containing 9 |
C00000919
|
9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 |
C00000919
|
9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 |
C00000919
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00000919
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000919
|
53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) |
C00000919
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00000919
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00000919
|
9071 | CLDN10, CPETRL3, OSP-L | claudin 10 |
C00000919
|
51208 | CLDN18, SFTA5, SFTPJ | claudin 18 |
C00000919
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000919
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00000919
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00000919
|
8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain |
C00000919
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00000919
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00000919
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00000919
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00000919
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000919
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00000919
|
64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) |
C00000919
|
1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 |
C00000919
|
1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 |
C00000919
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00000919
|
23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 |
C00000919
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000919
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00000919
|
2627 | GATA6 | GATA binding protein 6 |
C00000919
|
2633 | GBP1 | guanylate binding protein 1, interferon-inducible |
C00000919
|
81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa |
C00000919
|
373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00000919
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00000919
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00000919
|
2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) |
C00000919
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00000919
|
3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 |
C00000919
|
3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 |
C00000919
|
3226 | HOXC10, HOX3I | homeobox C10 |
C00000919
|
3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 |
C00000919
|
3449 | IFNA16, IFN-alphaO | interferon, alpha 16 |
C00000919
|
3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 |
C00000919
|
3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 |
C00000919
|
3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 |
C00000919
|
50805 | IRX4, IRXA3 | iroquois homeobox 4 |
C00000919
|
7779 | SLC30A1, ZNT1, ZRC1 | solute carrier family 30 (zinc transporter), member 1 |
C00002528
|
3691 | ITGB4, CD104 | integrin, beta 4 |
C00000919
|
3713 | IVL | involucrin |
C00000919
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00000919
|
3880 | KRT19, CK19, K19, K1CS | keratin 19 |
C00000919
|
3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 |
C00000919
|
3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 |
C00000919
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00000919
|
8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 |
C00000919
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000919
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000919
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00000919
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00000919
|
4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 |
C00000919
|
4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 |
C00000919
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00000919
|
3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00000919
|
4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 |
C00000919
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00000919
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000919
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000919
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00000919
|
5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 |
C00000919
|
5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 |
C00000919
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00000919
|
57088 | PLSCR4, TRA1 | phospholipid scramblase 4 |
C00000919
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00000919
|
5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D |
C00000919
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00000919
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000919
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00000919
|
5950 | RBP4, RDCCAS | retinol binding protein 4, plasma |
C00000919
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00000919
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000919
|
4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 |
C00000919
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000919
|
9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) |
C00000919
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000919
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000919
|
7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) |
C00000919
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00000919
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00000919
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00000919
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#300018 | 46,xy sex reversal 2; srxy2 |
P51843
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#300200 | Adrenal hypoplasia, congenital; ahc |
P51843
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#610251 | Alcohol sensitivity, acute |
P05091
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#614546 | Efavirenz, poor metabolism of |
P20813
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#606824 | Glucose/galactose malabsorption; ggm |
P13866
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P38398 |
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#233100 | Renal glucosuria; glys1 |
P31639
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P16109
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01261 | Congenital glucose-galactose malabsorption (GGM) |
P13866
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01126 | Familial renal glucosuria (FRG) |
P31639
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00552 | Glycerol kinase deficiency (GKD) |
P51843
(related)
|
H00607 | 46,XY disorders of sex development (Disorders of gonadal development) |
P51843
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D008175 | Lung Neoplasms |
C00003794
C00000919 |
D002318 | Cardiovascular Diseases |
C00000919
|
D000707 | Anaphylaxis |
C00003794
|
D003110 | Colonic Neoplasms |
C00003794
|
D007249 | Inflammation |
C00003794
|
D007680 | Kidney Neoplasms |
C00003794
|
D005831 | Genital Diseases, Female |
C00002528
|
D011230 | Precancerous Conditions |
C00003794
|
D000435 | Alcoholic Intoxication |
C00000919
|
D001145 | Arrhythmias, Cardiac |
C00000919
|
D053627 | Asthenozoospermia |
C00000919
|
D002545 | Brain Ischemia |
C00000919
|
D006528 | Carcinoma, Hepatocellular |
C00000919
|
D011471 | Prostatic Neoplasms |
C00002528
|
D003930 | Diabetic Retinopathy |
C00000919
|
D056486 | Drug-Induced Liver Injury |
C00000919
|
D006526 | Hepatitis C |
C00000919
|
D015658 | HIV Infections |
C00000919
|
D006986 | Hypervitaminosis A |
C00000919
|
D008107 | Liver Diseases |
C00000919
|
D008113 | Liver Neoplasms |
C00000919
|
D008114 | Liver Neoplasms, Experimental |
C00000919
|
D009369 | Neoplasms |
C00000919
|
D009845 | Oligospermia |
C00000919
|
D013272 | Stomach Diseases |
C00000919
|
D013276 | Stomach Ulcer |
C00000919
|